The Top Six Ways Trump’s Policies Will Impact Pharmacies February 23, 2017By Christine BlankHow the new Trump administration will affect everything from the ACA to the FDA. Value-based care takes over J.P. Morgan Healthcare Conference 2017 January 23, 2017By Marc O'ConnorIs the drive to value-based care really accelerating? What can be done amidst all of the uncertainty? Expert shares insights from the J.P. Morgan 35th Annual Healthcare Conference. Four ways Medicare Part D has affected costs for diabetic patients November 22, 2016By Tracey WalkerUnderstand Medicare Part D’s design and its coverage gap to offer the most affordable prescription drug options for patients. BLOG: Close call for Rx marketers on Part D
March 12, 2014Why would HHS disrupt Part D when it's been a success for plans and for seniors?
Pharmacy groups applaud Part D backpedal March 11, 2014By Julie MillerAMCP and NCPA are generally relieved that feds won't interfere with drug prices Antidepressants may be kicked off protected drug list February 27, 2014By Julie MillerSix protected drug classes could be whittled down to three by 2016 Fact File: New Part D rule changes February 26, 2014By Julie MillerGet caught up on CMS proposals for Part D networks, mail order and price negotiations Part D's history might be a benchmark for ACA rollout
January 01, 2014Will ACA exchanges earn 90% satisfaction ratings someday?
Exchange formularies need flexibility beyond PPACA October 01, 2013By Mari EdlinPharmacy leaders say benchmark plans too limited and PPACA too prescriptive